Home > HCP > What is GelX?

What is GelX®?

GelX® is a mucoprotectant brand available in a 100ml oral solution spray, indicated for the prevention and treatment of oral mucositis and suitable for use in all ages and all
ethnic cultures. 1

Provides a bio-adhesive barrier for durable protection

Blocks exposed nerve endings and coats oral lesions to soothe and relieve pain 1,4

Aids patients in coping with oral mucositis and completing long-term treatment goals. 5

How does it work? 12,13

Icon Mode of Action

Mode of Action


Biomechanical Benefits

  • Bio adhesive barrier for durable protection
  • Blocks exposed nerve endings and coats oral lesions to soothe and relieve pain
  • Protects ulcerated tissue from further injury and bacterial colonisation

Anti-inflammation

  • Adheres to mucosal surface and delivers a bioactive zinc-taurine complex
  • Releases bioactive zinc-taurine complex into epithelial cells
  • The combined anti-inflammatory properties of zinc and taurine have demonstrated a synergistic biological effect in vitro by regulating COX-2 mediated prostaglandins and inflammatory cytokines
Icon Ingredients

Ingredients


Polyvinylpyrrolidone (PVP)

  • High molecular weight polymer
  • Coating and encapsulation of tissues
  • Provides a water-permeable film

Zinc Gluconate and Taurine

  • Forms a bio-active zinc-taurine complex 
under physiological conditions
  • Provides excellent bacteriostatic qualities without cyto-toxicity seen in other preservative systems
  • Effective in addressing mineral deficiency and inflammatory processes associated with oral pain and discomfort
  • Found to exert anti-microbial, 
anti-inflammatory, free radical scavenging, and analgesic effects
  • Delays onset of oral mucositis by 
inhibiting inflammatory cycle
download formulary guide

Clinical Evidence

  • The use of GelX® in the prevention and soothing of cancer-therapy-induced oral mucositis has been clinically proven in children and adults suffering from a variety of malignancies. 5,6,7
  • The preventive use of GelX® when starting radiotherapy has been shown to reduce the severity of mucositis. 5
  • The preventive use of GelX® has been shown to reduce the severity of oral mucositis (WHO scale) during chemotherapy and improve eating and swallowing in children. 6,7
  • GelX® reduces the need to interrupt chemotherapy or radiotherapy treatment due to oral mucositis. 5
  • GelX® reduces pain and swallowing difficulties caused by chemotherapy-induced oral mucositis in children with cancer. 6
Clinical Efficacy
Image